ArticleHuman vaccines & immunotherapeutics2019

GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization.

Domingo Barber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.